HPV infection and immunochemical detection of cell-cycle markers in verrucous carcinoma of the penis by Stankiewicz, Elzbieta et al.
UN
CO
RR
EC
TE
D P
RO
OF
HPV infection and immunochemical detection
of cell-cycle markers in verrucous carcinoma
of the penis
Ela Stankiewicz1, Sak Kudahetti1, David M Prowse1, Elena Ktori1, Jack Cuzick2,
Laurence Ambroisine2, Xiaoxi Zhang1, Nicholas Watkin3, Catherine Corbishley3
and Daniel M Berney1
1Centre for Molecular Oncology and Imaging, Barts and The London School of Medicine and Dentistry,
London, UK; 2Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of
Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary, University of
London, London, UK and 3The Cellular Pathology Department, St George’s Hospital, Tooting, London, UK
Penile verrucous carcinoma is a rare disease and little is known of its aetiology or pathogenesis. In this study
we examined cell-cycle protein expression and correlation with human papillomavirus infection in a series of 15
pure penile verrucous carcinomas from a single centre. Of 148 penile tumours, 15 (10%) were diagnosed as pure
verrucous carcinomas. The expression of the cell-cycle-associated proteins p53, p21, RB, p16INK4A and Ki67
were examined by immunohistochemistry. Human papillomavirus infection was determined by polymerase
chain reaction to identify a wide range of virus types. The expression of p16INK4A and Ki67 was significantly
lower in verrucous carcinoma than in usual type squamous cell carcinoma, whereas the expression of p53, p21
and RB was not significantly different. p53 showed basal expression in contrast to usual type squamous cell
carcinoma. Human papillomavirus infection was present in only 3 out of 13 verrucous carcinomas. Unique low-
risk, high-risk and mixed viral infections were observed in each of the three cases. In conclusion, lower levels of
p16INK4A and Ki67 expressions differentiate penile verrucous carcinoma from usual type squamous cell
carcinoma. The low Ki67 index reflects the slow-growing nature of verrucous tumours. The low level of p16INK4A
expression and human papillomavirus detection suggests that penile verrucous carcinoma pathogenesis is
unrelated to human papillomavirus infection and the oncogenes and tumour suppressor genes classically
altered by virus infection.
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Verrucous carcinoma is a rare low-grade squamous
cell carcinoma with slow invasive growth and lack
of metastasis. It was first described in 1948 by
Lauren V Ackerman in the oral cavity.1 Since then it
also has been described at other sites, including the
anus, female genitalia and penis.2–4 Grossly, verru-
cous carcinomas are exophytic white-grey papillo-
matous neoplasms. Microscopically, hyperkeratosis,
papillomatosis and acanthosis are present; koilo-
cytosis is absent. The cells are extremely well
differentiated with prominent intercellular brid-
ges. The base of the tumour is broad, with
pushing, regular borders composed of broad bulbous
projections.5–8
Squamous cell carcinoma of the penis is itself rare
and represents 0.3–0.5% of male malignancies in
Europe and the United States of America.9 The most
common type of penile squamous cell carcinoma is
the usual type (70%), followed by basaloid (10%)
and a heterogenous groups of ‘verruciform’ tumours
(20%).5 However, mixed tumours commonly exist of
usual type squamous cell carcinoma and one or
more type of verruciform tumour. Verruciform
lesions include verrucous carcinoma, warty carci-
noma (also known as Buschke–Lowenstein tumour
(BLT) or giant condyloma accuminatum) and papil-
lary squamous cell carcinomas, not otherwise
specified.8,10 The reported frequency of penile
verrucous carcinoma is low and accounts for
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3–20% of all penile cancers.5,6,11–13 However, identi-
fication of cases from the literature is sometimes
difficult because of the varied nomenclature used in
the past, often regarding them as the same lesion as
BLT.14,15 Risk factors for penile verrucous carcinoma
seem to be similar as for penile cancer in general,
which are poor hygiene, phimosis and chronic
inflammation16 but no systematic case series has
been studied. The human papillomavirus (HPV) role
in pathogenesis of these tumours is not certain
because of small number of cases available for
studies. One large study on penile cancer has found
verrucous carcinoma to be always associated with
squamous hyperplasia.17 The treatment of choice for
penile verrucous carcinoma is similar to verrucous
cases from other sites and involves wide surgical
excision, less commonly, radiation or chemother-
apy.4,18 Untreated or inadequately excised verrucous
carcinoma can progress locally but distant metas-
tasis are exceptional.,5,16 The rarity of the disease
makes it difficult to study, and mostly case reports
or studies on small series are available.
The aim of this project was to study the HPV status
in penile verrucous carcinomas and its potential
association with the immunohistochemical detection
of key cell-cycle proteins: p53, p21, p16INK4A RB and
Ki67 to elucidate their pathogenesis.
Materials and methods
We retrospectively retrieved 148 penile squamous
cell carcinomas from the Cellular Pathology Depart-
ment of St George’s Hospital. Of the samples, 29
were penile verruciform tumours—15 pure verru-
cous carcinomas and 14 mixed type—which we
excluded from our study. Other squamous cell
carcinoma types were usual type (97), basaloid
(17) and warty (5). The tumours were obtained
from excision biopsy, glansectomy or penectomy.
They were graded into groups as: well (grade 1),
moderately (grade 2) and poorly differentiated
(grade 3) on the degree of the cytological pleomorph-
ism, mitotic rate and architectural atypia. For stage,
the TNM (2002) classification of penile cancer was
used.19 The key pathologic and clinical features are
listed in Table 1. Results from the penile verrucous
carcinomas were compared with those from usual
type squamous cell carcinomas.
Immunohistochemistry
Tissue microarray blocks were prepared using a
manual microarrayer. Tissue cores (3 1 mm) were
taken from each tissue sample. Tissue sections were
cut at 4mm thickness. A heat-induced antigen
retrieval method with citrate buffer pH6.0 was
applied. Immunochemistry was performed using
the avidin–biotin technique with the antibodies
against p53 (Dako; M7001), p21 (Dako; M7202), RB
(Novocastra; NCL-RB-358), p16INK4A tumour sup-
pressor protein (Neomarkers, MS-1064-PO) and
Ki67 (Dako; A0047). Dilutions were as follows: p53
and p21 1:1000, RB 1:50, p16INK4A and Ki67 1:100.
The positive controls were CIN III for p16INK4A
placenta for p21, anaplastic thyroid cancer for p53
and tonsil for RB and Ki67. The immunohistochem-
istry results are summarized in Table 2. Examples of
immunostaining are shown in Figure 1. The staining
pattern in case of p53, p21, RB and Ki67 was
nuclear. p16INK4A showed both nuclear and cyto-
plasmic staining. Results were compared with
expression in usual type squamous cell carcinomas.
Sections were scored semiquantitatively by a
consultant genitourinary pathologist (DB). For nu-
clear positivity each core was given an estimated
visual score as 0–100%, representing the percentage
of positively stained neoplastic nuclei. Nuclear
score alone was applied to assess p53 and Ki67
expression (as expression was always strong). For
nuclear expression of p16INK4A RB and p21 antibody,
the intensity of staining was also measured using
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Table 1 Pathologic and clinical features for pure penile verrucous carcinomas
Patient
number
Patient
age
Surgery type Width
(mm)
Depth
(mm)
Type of
growth
Tumour
grade
Tumour
stage
Presence
of BXO
1 50 Glansectomy 22 3 Endophytic 2 1 No
2 73 Glansectomy 11 3 Mixed 1 1 No
3 81 Distal penectomy 42 40 Mixed 1 2 No
4 74 Glansectomy 14 3 Exophytic 1 2 No
5 71 Glans excision biopsy 15 6 Endophytic 1 2 Yes
6 84 Glansectomy 22 14 Exophytic 1 1 No
7 35 Circumcision 25 2.4 Exophytic 1 1 No
8 73 Radical penectomy 80 14 Exophytic 2 1 No
9 60 Glansectomy 17 7 Exophytic 1 2 No
10 81 Glansectomy 20 7 Exophytic 1 2 Yes
11 88 Glansectomy 24 8 Exophytic 2 2 No
12 61 Glans resurfacing 13 1 Exophytic 1 1 No
13 66 Partial glansectomy 36 8 Exophytic 1 1 Yes
14 35 Glansectomy 25 4 Exophytic 1 1 No
15 63 Glansectomy 27 17 Endophytic 1 2 No
Q1
Q2
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the scores: 1 (low), 2 (medium) and 3 (high). The
final score was deduced by multiplying the percen-
tage of staining by intensity to give an expression
score from 0 to 300. Cytoplasmic expression of
p16INK4A was determined by intensity of staining
alone. The core with highest score was chosen for
each patient for analysis.
Statistical analysis was performed using StatsDir-
ect software, version 2.60.6000. The correlations
between antibodies were evaluated using Spear-
man’s test. The association between the antibody
and the tumour subtype or HPV infection was
evaluated by w2-test. Where the number of patients
was low, Fisher’s exact probability test was used.
The cut-off points for antibodies were as follows:
40 for p16INK4A, Z5% for p53 and p21, Z20% for
Ki67 and Z240 for high expression of RB. In all
analyses Po0.05 was considered to be statistically
significant.
HPV Analysis
A total of 13 original wax blocks from verrucous
carcinoma cases were suitable for DNA extraction.
DNA was extracted with a QIAamp DNA Mini kit
(category no. 51304; Qiagen, Crawley, UK). b-Globin
polymerase chain reaction (PCR) was performed
using primers B1 and B19 to confirm the adequacy
of the extracted DNA. Validated samples were tested
for the presence of HPV DNA by a broad-spectrum
HPV PCR method using SPF10 primers, which
amplify a 65-bp fragment of the L1 open reading
frame and HPV genotypes identified by the INNO-
LiPA line probe assay (Innogenetics NV, Ghent,
Belgium).20 As a positive control, a known HPV-
positive cervical cancer sample was used. Mouse
tissue served as negative control. To ensure speci-
ficity of the method negative samples were included
alongside every 5–10 regular samples.
Results
Immunohistochemistry
Ki67
The expression of proliferation marker Ki67 in
penile verrucous carcinomas was mostly basal in
nature (Figure 1a) and was positive in 67% (10/15)
cases. The level of expression varied from a
minimum of 10 to a maximum of 30% of positively
stained neoplastic nuclei, with a mean of 19% and
median of 20%. Ki67 expression in penile verrucous
carcinomas was significantly lower than that seen in
usual type penile squamous cell carcinomas
(P¼ 0.0108).
p53
p53 expression in penile verrucous carcinomas was
present in 87% (13/15) tumours, mostly confined to
the basal or suprabasal layers, which contrasted
with more diffuse patterns in usual type squamous
cell carcinomas (Figure 1b). The percentage of
positive-cell nuclei varied from 0 to 60%, with a
mean of 15% and median of 10%. No significant
difference in p53 expression was observed between
penile verrucous carcinomas and usual type penile
squamous cell carcinomas (P¼ 0.7326).
p21
p21 was positive in 77% (10/13) of patients. The
percentage of p21 stained cells was usually low and
the intensity was weak (Figure 1c). The calculated
expression scores for p21 expression in penile
verrucous carcinomas ranged from 0 to 60 with
mean of 18 and median 10. The expression of p21 in
penile verrucous carcinomas was not significantly
different from that in usual type penile squamous
cell carcinomas (P40.9999).
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Table 2 Immunohistochemistry and PCR results for pure penile verrucous carcinomas
Verrucous
sample
Nuclear p16
(0–300)
Cytoplasmic p16
(0–3)
RB
(0–300)
p53
(0–100)
p21
(0–300)
Ki67
(0–100)
HPV type
detected
1 40 1 270 1 40 30 –
2 0 0 240 5 5 10 –
3 0 0 180 5 NDa 10 NDb
4 0 0 270 60 0 10 –
5 0 0 270 5 20 20 –
6 0 0 240 5 10 20 –
7 0 0 240 10 10 20 51, 52
8 0 1 240 10 20 20 –
9 0 0 210 40 40 30 NDb
10 0 0 270 40 NDa 10 31, 33, 44, 45
11 0 0 300 10 5 20 –
12 0 0 270 10 0 20 –
13 0 0 240 0 1 10 –
14 0 0 240 10 60 30 11
15 0 0 240 20 20 30 –
(–) in the last column indicate HPV-negative.
a
ND: lack of data due to random tissue loss from tissue microarray.
b
ND: lack of data due to inadequate DNA.
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RB
RB expression in verrucous carcinomas was
often strong and involved 60% and more nuclei
(Figure 1d). It was strongly positive in 87% (13/15)
of cases. RB expression varied from a score of 180 to
300 with mean of 248 and median of 240. There was
a trend for higher RB expression in penile verrucous
carcinomas than usual type squamous cell carcino-
mas (P¼ 0.0441).
p16INK4A
Expression of nuclear p16INK4A in verrucous carci-
nomas was not detected in 14 of 15 samples (93%).
Only 1 sample was positive with an expression
npg_Mpath_modpathol200977
Figure 1 Immunostaining results for penile verrucous carcinoma. (a) Suprabasal nuclear positivity for Ki67 expression. (b) Strong
positivity of p53 in basal areas of the tumour. (c) p21 expression, showing scattered staining only. (d) Strong RB expression throughout
the tumour. (e) p16INK4A expression showing both cytoplasmic and nuclear positivity. All pictures magnification:  200.
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score of 40. Cytoplasmic expression of p16INK4A was
also absent in most of the samples with only two
samples weakly stained (Figure 1e). There was a
significant difference in p16INK4A nuclear
(P¼ 0.0019) and cytoplasmic (P¼ 0.019) expression
between penile verrucous carcinomas and usual
type penile squamous cell carcinomas.
HPV Infection
HPV DNA was present in 3 out of 13 (23%) of penile
verrucous carcinoma cases studied. Low-risk (HPV
11), high-risk (HPV 51, 52) and mixed HPV infec-
tions (31,33,44,45) were observed in the verrucous
carcinomas. None of verrucous cases contained
high-risk HPV 16 type, which was the most common
type in usual type penile squamous cell carcinomas.
Discussion
Penile verrucous carcinoma is extremely rare, not
well characterized and its aetiology poorly under-
stood. In early studies, association with HPV
infection had been made, especially low-risk types
6 and 11, but confusion over classification of
verruciform tumours often resulted in regarding
verrucous carcinoma as one entity with BLT21
clouding the evidence. Other authors suggested that
screening for HPV may help in differentiating
verrucous carcinoma from BLT, as verrucous carci-
noma has been found to be negative for HPV
infection.22–28 However, those studies often utilized
for HPV detection the in situ hybridization method,
which is not as sensitive as PCR.29 A review of
literature on HPV infection in penile verrucous
carcinoma is presented in Table 3. In general,
regardless of the detection method, verrucous
carcinoma is still considered as cancer not related
to HPV infection.12,13,30,31 We used a broad-spectrum
HPV PCR method with SPF10 primers which
amplify a 65-bp fragment of the L1 open reading
frame and HPV genotypes identified by the
INNO-LiPA line probe assay. This method is
considered as highly specific and extremely
sensitive for the simultaneous detection of multiple
HPV types in clinical samples, including formalin-
fixed, paraffin-embedded material.32 We detected
HPV DNA in 23% (3/13) of penile verrucous
carcinomas and in 59% (38/64) of usual type
squamous cell carcinomas. None of the HPV-
positive verrucous cases contained HPV16 type,
whereas it was the most prevalent type in usual
type squamous cell carcinomas. Two authors of
this article applied the same method before on an
independent cohort (from the Barts and the
London NHS Trust) of penile squamous cell carci-
nomas, penile lichen sclerosus and late stage
cervical carcinoma with HPV positivity of 33, 54
and 92%, respectively.20 According to the largest
study of HPV infection in penile cancer by Rubin
et al,33 only basaloid and warty types of penile
squamous cell carcinoma are consistently associ-
ated with HPV, whereas in verrucous and usual
type squamous cell carcinomas, HPV infection is
present only in 33.3 and 34.9% of cases, respec-
tively. They included 106 keratinizing, 15 basaloid,
12 verrucous and 5 warty cases. Our results for
verrucous cases confirm the low incidence of HPV
infection in this cancer type. Within three HPV-
positive verrucous carcinoma cases, one contained
low-risk HPV, one only high-risk types and the
third one mixed low and high-risk HPV types. Both
low- (HPV 11) and high-risk (HPV 16 and 52) types
have been reported previously in verrucous
cases, including the Rubin et al study,33 where they
found HR-HPV in two of their four HPV-positive
verrucous cases.
p53 is a tumour suppressor protein, commonly
inactivated in cancer by mutation, leading to its
accumulation in transformed cells. However, in
HPV related cancers, expression of viral E6 protein
is known to inactivate p53 through its downregula-
tion. Therefore, an inverse correlation between HPV
npg_Mpath_modpathol200977
Table 3 Summary of published data on penile verrucous carcinoma associated with HPV infection
Reference Method detection range HPV detected No/total (%)
Kiyabu et al (1986) PC HPV 16, 18 0 0/3 (0)
Villa and Lopes26 Southern blot HPV6, 11, 16, 18 0 0/1 (0)
Varma et al27 ISH HPV6, 11, 16, 18, 31, 33, 35 0 0/4 (0)
PCR HPV6, 11, 16 0 0/4 (0)
Higgins et al28 ISH HPV6, 11, 16, 18, 31, 33 0 0/5 (0)
Masih et al23 Isotopic ISH HPV 6, 11, 16, 18, 31 0 0/10 (0)
Chan et al13 PCR HPV 16, 18 0 0/7 (0)
Cupp et al31 PCR HPV 16, 18 0 0/3 (0)
Dianzani et al (1998) PCR HPV 6, 11, 16, 18, 31, 33 HPV11 1/1 (100)
Rubin et al33 PCR Wide range, SPF 10 primers HPV6, 16, other 4/12 (33.3)
Ferreux et al47 PCR Wide range HPV6 1/1 (100)
Seneba et al29 ISH HPV6, 11, 16, 18, 31, 33 HPV6 1/1 (100)
PCR Wide range, SPF 10 primers HPV6 1/1 (100)
Wong et al (2007) Not specified HPV6 1/1 (100)
Stankiewicz et al (2008) PCR Wide range, SPF 10 primers HPV 11, 31, 33, 44, 45, 51, 52 3/13 (23)
PCR, polymerase chain reaction; ISH, in situ hybridization.
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positivity and p53 overexpression has been sug-
gested, with special regards to cervical, vaginal and
vulvar carcinomas.34
We used clone DO-7 p53 antibody, which prefer-
entially detects mutated p53 protein or high levels
of wild-type protein. We detected p53 expression in
87% (13/15) of the penile verrucous carcinomas,
which was similar to the usual type squamous cell
carcinomas, but the percentage of stained cells was
low (in most cases only 5–10% of cells stained).
Most of the staining was basal or suprabasal in
nature. There was no negative correlation between
HPV infection and p53 expression in usual type or
verrucous carcinomas; in fact all three HPV-positive
verrucous cases were also p53-positive. Lam and
Chan35 have detected a higher p53 expression using
a similar method and the same antibody clone. All 5
cases of their penile verrucous carcinomas and 89%
of usual type squamous cell carcinomas were p53-
positive, also mostly in basal cells. Similar to our
study, they did not observe an inverse correlation
between HPV and p53 overexpression. Another
study by the same authors30 has shown no p53
expression in all seven verrucous cases studied and
only in 49% of usual type squamous cell carcino-
mas. The explanation could be in a higher cut-off
point used in that study. Ouban et al36 detected
weak, scattered p53 expression in penile verrucous
carcinomas, which was lower than in usual type
squamous cell carcinomas, expressing strong nucle-
ar staining. These verrucous carcinomas also over-
expressed MDM2 protein, which could explain p53
downregulation, as MDM2 is a p53-negative reg-
ulator. Adegboyega et al37 detected p53 only in the
lower third of epithelium in their mixed series of 19
verrucous carcinomas from different sites, including
3 cases of penile verrucous carcinoma, whereas
usual type squamous cell carcinomas showed the
stained cells through the entire thickness of the
epithelium. Pilotti et al,24 who studied five cases of
vulvar verrucous carcinoma and two cases of BLT,
did not detect p53 in verrucous carcinoma samples.
Similarly, Gualco et al3 did not find p53 (mutated or
wild type) or HPV infection in their series of 10
cases of vulvar verrucous carcinoma, which in their
opinion confirmed the low malignant behaviour of
this lesion. The discrepancies in p53 expression in
verrucous carcinoma may be the result of the limited
number of samples available for study. The differ-
ences in tissue fixation or antigen retrieval methods
could also influence the outcome. Furthermore,
considering complexity of p53 pathway and its
diverse regulatory mechanisms, any changes in
physiological conditions within the tissue may
greatly affect expression levels and activity of
wild-type protein and its mutant forms at a given
time.38 Ideally, additional study of mutations within
the p53 gene would confirm the mutational status of
p53 in those samples.
Our series of penile verrucous carcinomas is the
largest studied and suggests that p53 overexpression
is common in penile verrucous carcinoma and is not
affected by HPV infection. However, similar to other
studies, the percentage of p53-positive cells is not
high.
p53 regulates expression of another important
protein in cell-cycle control, p21. p21 is a CDK
inhibitor which is upregulated by p53 in response to
DNA damage and causes cell-cycle arrest. p21 is
rarely overexpressed in human cancers. Loss of p21
expression as well as overexpression has been
related to poor prognosis in some cancers.39 In this
study, we detected p21 expression in 77% (10/13) of
penile verrucous carcinoma at low levels. Lam and
Chan35 detected p21 in 40% of penile squamous cell
carcinomas, including all five cases of verrucous
carcinoma; however, staining was weak, similar to
our study. They also noted an inverse correlation
between p21 and p53 in half of the squamous cell
carcinomas and four of five verrucous carcinomas,
which is in agreement with the existence of a
negative feedback loop between p53 and p21
expression.40 Among our cases we found two
tumours p21/p53þ and 1 tumour p21þ /p53,
however, there was no correlation between p53 and
p21 expressions. This might be explained by the
possible induction of p21 in a p53 independent
way.41 Adegboyega et al37 found p21 expression in
all 19 cases of verrucous carcinoma from different
sites and it was expressed either in lower third of
epithelium (58%) or through the entire thickness of
the epithelium (42%). Our results for p21 expres-
sion in penile verrucous carcinoma are higher than
those in the above-mentioned studies and might be
more accurate as our series included 15 penile
verrucous carcinoma to compare with 5 cases from
the Lam and Chan35 study or 3 penile verrucous
carcinoma from the Adegboyega et al report.37
One of the main functions of p21 is p53-
dependent cell-cycle arrest, which should lead to
decreased proliferation. Surprisingly, we found a
positive correlation between p21 and the prolifera-
tion marker Ki67 in verrucous carcinoma
(P¼ 0.0003). Cheung et al42 found in cervical cancer
a positive correlation of p21 with advanced tumour
stage. He suggested that increase in p21 expression
represented an ineffective cellular response to
increased cellular activity and did not contribute
to tumour development. A positive correlation
between p21 and Ki67 in squamous cell carcinomas
of the skin from sun-exposed and anogenital sites
has also been reported and p21 function linked to
cell differentiation.43
Another tumour suppressor protein involved in
cell-cycle control and progression is the retinoblas-
toma protein (RB). In its active, hypophosphorylated
state, it binds E2F proliferation factors and inhibits
the cell passage through the G1 restriction point and
entering the S phase. RB mutations, consistent with
loss of RB function, have been identified in a wide
spectrum of cancers. In tumours infected with HPV,
RB is often inactivated and downregulated by viral
npg_Mpath_modpathol200977
Penile verrucous carcinoma
E Stankiewicz et al
6
Modern Pathology (2009), 1–9
UN
CO
RR
EC
TE
D P
RO
OF
E7 protein.44 In our verrucous carcinoma series all
tumours studied for HPV infection highly expressed
RB protein. In general, we found high expression of
RB in 87% (13/15) of verrucous carcinomas, which
most probably reflects normal cell responses to
increased proliferation during tumuorigenesis and
confirms the lack of HPV involvement in RB
regulation in this particular cancer. In contrast, we
found an inverse correlation between HPV infection
and RB protein expression in usual type squamous
cell carcinomas (unpublished data), suggesting a
different aetiology for those tumours. To our knowl-
edge there is no other RB study on penile verrucous
carcinoma apart from Adegboyega et al,37 who
included three penile cases in their verrucous
carcinoma series and found high RB expression in
95% of tumours, which is very similar to our results.
p16INK4A tumour suppressor protein is a CDK4
inhibitor and its expression can prevent cell-cycle
progression by inhibiting the phosphorylation of
RB. p16INK4A is commonly not expressed in the
tumour cells due to homozygous deletion, muta-
tions or promoter methylation.45 However, in tu-
mours with HPV infection, accumulation of p16INK4A
is a well-known event in response to RB inactivation
by viral E7 protein.46 We detected a lack of p16INK4A
nuclear and cytoplasmic expression in our penile
verrucous carcinoma series in 93% (14/15) and 87%
(13/15) of cases, respectively. Ferreux et al47 found
at least three alternative mechanisms targeting the
p16INK4A/cyclin D/RB pathway in penile carcinoma.
One of them involved p16INK4A overexpression
found in HPV-positive cases, the result of inactivat-
ing RB by viral E7 protein. Another two mechanisms
were found in the absence of HPV infection and
involved silencing of the p16INK4A gene followed by
lack of p16INK4A protein expression: one by promoter
methylation, which they found in 15% of the
carcinomas, the other by expression of the BMI-1
PcG gene detected in 10% of the carcinomas. Within
their series there was only one case of verrucous
carcinoma, and it was HPV6-positive, however, this
tumour did not express p16INK4A protein, exhibit
p16INK4A promoter methylation or BMI-1 staining,
which suggests additional mechanism of p16INK4A
inactivation. Study by two of the authors of this
paper20 confirmed the inverse correlation between
HPV16/18 and p16INK4A in usual type squamous cell
carcinomas and penile lichen sclerosus. We found
the same correlation in our usual type samples but
not in verrucous, which again suggests the connec-
tion to HPV infection only in usual type carcinoma.
Ki-67 protein is present during all active phases of
the cell cycle (G1, S, G2 and mitosis), but is absent
from resting cells (G0), which makes it an excellent
marker for determining the so-called growth fraction
of a given cell population. In our study, we detected
significantly lower Ki67 expression in penile verru-
cous carcinomas than in usual type squamous cell
carcinomas (67 and 93%, respectively, P¼ 0.0108).
This expression was predominantly restricted to the
basal layers. Very similar results have been reported
in vulvar verrucous carcinoma, where Ki67 expres-
sion was present in 10–40% of cells, and in 70–80%
of cases positivity was found in the basal layer of the
neoplastic epithelium.3 Study of 19 cases of verru-
cous carcinoma from larynx, penis, oral mucosa and
skin revealed the Ki67 staining in all verrucous
carcinoma tumours and also only in basal and
suprabasal cells, which was different from invasive
squamous cell carcinomas, showing Ki67 expression
diffusely throughout the whole malignant epithe-
lium.37
Conclusions
Penile verrucous carcinoma, similar to other verru-
cous carcinomas, is a slow-growing tumour and this
is reflected in the low Ki67 index. The lack of
p16INK4A expression also differentiates these tu-
mours biologically from usual type squamous cell
carcinomas. The overexpression of p53 and RB
proteins combined with the low incidence of
p16INK4A expression and HPV infection in verrucous
carcinoma suggests that the virus plays a limited
role in tumuorigenesis in this cancer type. Further
studies on larger series are necessary to establish the
significance of molecular changes in the develop-
ment of the disease and their potential usefulness
for designing treatment strategies.
Acknowledgement
This project is generously supported by The Jean
Shanks Foundation and The Orchid Cancer Appeal.
Conflict of interest
None.
References
1 Ackerman LV. Verrucous carcinoma of the oral cavity.
Surgery 1948;23:670–678.
2 Cuesta KH, Palazzo JP, Mittal KR. Detection of human
papillomavirus in verrucous carcinoma from HIV-
seropositive patients. J Cutan Pathol 1998;25:165–170.
3 Gualco M, Bonin S, Foglia G, et al. Morphologic and
biologic studies on ten cases of verrucous carcinoma of
the vulva supporting the theory of a discrete clinico-
pathologic entity. Int J Gynecol Cancer 2003;13:
317–324.
4 Kraus FT, Perezmesa C. Verrucous carcinoma. Clinical
and pathologic study of 105 cases involving oral cavity,
larynx and genitalia. Cancer 1966;19:26–38.
5 Cubilla LC, Velazquez EF, Barreto JE, et al. The Penis
Sternberg’s Diagnostic Surgical Pathology, 4th edn
Lippincott Williams & Wilkins: Philadelphia,
2004;pp:2233–2276.
6 Velazquez EF, Cubilla AL. Penile squamous cell
carcinoma: anatomic, pathologic and viral studies in
npg_Mpath_modpathol200977
Penile verrucous carcinoma
E Stankiewicz et al
7
Modern Pathology (2009), 1–9
UN
CO
RR
EC
TE
D P
RO
OF
Paraguay (1993–2007). Anal Quant Cytol Histol
2007;29:185–198.
7 Cubilla AL. The role of pathologic prognostic factors in
squamous cell carcinoma of the penis. World J Urol
2009;27:169–177.
8 Cubilla AL. The penis In: Yong RH, Srigley JR, Amin
MB, Ulbright TM and Cubilla AL (eds). Atlas of Tumor
Pathology. Tumors of the Prostate Gland, Seminal
Vesicles, Male Urethra, and Penis 3rd edn. Armed
Forces Institute of Pathology: Washington, DC, 2000,
pp 403–475.
9 Narayana AS, Olney LE, Loening SA, et al. Carcinoma
of the penis: analysis of 219 cases. Cancer
1982;49:2185–2191.
10 Cubilla AL, Velazques EF, Reuter VE, et al. Warty
(condylomatous) squamous cell carcinoma of the
penis: a report of 11 cases and proposed classification
of ‘verruciform’ penile tumors. Am J Surg Pathol
2000;24:505–512.
11 Cubilla AL, Reuter V, Velazquez E, et al. Histologic
classification of penile carcinoma and its relation to
outcome in 61 patients with primary resection. Int J
Surg Pathol 2001;9:111–120.
12 Gregoire L, Cubilla AL, Reuter VE, et al. Preferential
association of human papillomavirus with high-
grade histologic variants of penile-invasive squa-
mous cell carcinoma. J Natl Cancer Inst
1995;87:1705–1709.
13 Chan KW, Lam KY, Chan AC, et al. Prevalence of
human papillomavirus types 16 and 18 in penile
carcinoma: a study of 41 cases using PCR. J Clin Pathol
1994;47:823–826.
14 McKee PH, Lowe D, Haigh RJ. Penile verrucous
carcinoma. Histopathology 1983;7:897–906.
15 Johnson DE, Lo RK, Srigley J, et al. Verrucous
carcinoma of the penis. J Urol 1985;133:216–218.
16 Bunker CB. Topics in penile dermatology. Clin Exp
Dermatol 2001;26:469–479.
17 Cubilla AL, Velazquez EF, Young RH. Epithelial
lesions associated with invasive penile squamous cell
carcinoma: a pathologic study of 288 cases. Int J Surg
Pathol 2004;12:351–364.
18 Seixas AL, Ornellas AA, Marota A, et al. Verrucous
carcinoma of the penis: retrospective analysis of
32 cases. J Urol 1994;152:1476–1478; discussion
1478–1479.
19 Sobin LH, Wittekind C. TNM Classification of
Malignant Tumours 6th edn. Wiley-Liss: New York,
2002, p 239.
20 Prowse DM, Ktori EN, Chandrasekaran D, et al. Human
papillomavirus-associated increase in p16INK4A ex-
pression in penile lichen sclerosus and squamous cell
carcinoma. Br J Dermatol 2008;158:261–265.
21 Noel JC, Vandenbossche M, Peny MO, et al. Verrucous
carcinoma of the penis: importance of human papillo-
mavirus typing for diagnosis and therapeutic decision.
Eur Urol 1992;22:83–85.
22 Kiyabu MT, Shibata D, Arnheim N, et al. Detection of
human papillomavirus in formalin-fixed, invasive
squamous carcinomas using the polymerase chain
reaction. Am J Surg Pathol 1989;13:221–224.
23 Masih AS, Stoler MH, Farrow GM, et al. Penile
verrucous carcinoma: a clinicopathologic, human
papillomavirus typing and flow cytometric analysis.
Mod Pathol 1992;5:48–55.
24 Pilotti S, Donghi R, D’Amato L, et al. HPV detection
and p53 alteration in squamous cell verrucous malig-
nancies of the lower genital tract. Diagn Mol Pathol
1993;2:248–256.
25 Haycox CL, Kuypers J, Krieger JN. Role of human
papillomavirus typing in diagnosis and clinical deci-
sion making for a giant verrucous genital lesion.
Urology 1999;53:627–630.
26 Villa LL, Lopes A. Human papillomavirus DNA
sequences in penile carcinomas in Brazil. Int J Cancer
1986;37:853–855.
27 Varma VA, Sanchez-Lanier M, Unger ER, et al.
Association of human papillomavirus with penile
carcinoma: a study using polymerase chain reaction
and in situ hybridization. Hum Pathol 1991;22:
908–913.
28 Higgins GD, Uzelin DM, Phillips GE, et al. Differing
prevalence of human papillomavirus RNA in penile
dysplasias and carcinomas may reflect differing etiol-
ogies. Am J Clin Pathol 1992;97:272–278.
29 Senba M, Kumatori A, Fujita S, et al. The prevalence
of human papillomavirus genotypes in penile
cancers from northern Thailand. J Med Virol
2006;78:1341–1346.
30 Lam KY, Chan AC, Chan KW, et al. Expression of p53
and its relationship with human papillomavirus in
penile carcinomas. Eur J Surg Oncol 1995;21:
613–616.
31 Cupp MR, Malek RS, Goellner JR, et al. The detection
of human papillomavirus deoxyribonucleic acid in
intraepithelial, in situ, verrucous and invasive carci-
noma of the penis. J Urol 1995;154:1024–1029.
32 Kleter B, van Doorn LJ, ter Schegget J, et al. Novel
short-fragment PCR assay for highly sensitive broad-
spectrum detection of anogenital human papilloma-
viruses. Am J Pathol 1998;153:1731–1739.
33 Rubin MA, Kleter B, Zhou M, et al. Detection and
typing of human papillomavirus DNA in penile
carcinoma: evidence for multiple independent path-
ways of penile carcinogenesis. Am J Pathol
2001;159:1211–1218.
34 Koyamatsu Y, Yokoyama M, Nakao Y, et al. A
comparative analysis of human papillomavirus types
16 and 18 and expression of p53 gene and Ki-67 in
cervical, vaginal, and vulvar carcinomas. Gynecol
Oncol 2003;90:547–551.
35 Lam KY, Chan KW. Molecular pathology and clinico-
pathologic features of penile tumors: with special
reference to analyses of p21 and p53 expression and
unusual histologic features. Arch Pathol Lab Med
1999;123:895–904.
36 Ouban A, Dellis J, Salup R, et al. Immunohistochem-
ical expression of Mdm2 and p53 in penile verrucous
carcinoma. Ann Clin Lab Sci 2003;33:101–106.
37 Adegboyega PA, Boromound N, Freeman DH. Diag-
nostic utility of cell cycle and apoptosis regu-
latory proteins in verrucous squamous carcinoma.
Appl Immunohistochem Mol Morphol 2005;13:
171–177.
38 Hall PA, McCluggage WG. Assessing p53 in clinical
contexts: unlearned lessons and new perspectives. J
Pathol 2006;208:1–6.
39 Roninson IB. Oncogenic functions of tumour suppres-
sor p21(Waf1/Cip1/Sdi1): association with cell senes-
cence and tumour-promoting activities of stromal
fibroblasts. Cancer Lett 2002;179:1–14.
40 Harris SL, Levine AJ. The p53 pathway: positive
and negative feedback loops. Oncogene 2005;24:
2899–2908.
npg_Mpath_modpathol200977
Q3
Penile verrucous carcinoma
E Stankiewicz et al
8
Modern Pathology (2009), 1–9
UN
CO
RR
EC
TE
D P
RO
OF
41 Missero C, Calautti E, Eckner R, et al. Involve-
ment of the cell-cycle inhibitor Cip1/WAF1 and
the E1A-associated p300 protein in terminal differ-
entiation. Proc Natl Acad Sci USA 1995;92:
5451–5455.
42 Cheung TH, Lo KW, Yu MM, et al. Aberrant expression
of p21(WAF1/CIP1) and p27(KIP1) in cervical carcino-
ma. Cancer Lett 2001;172:93–98.
43 Tron VA, Tang L, Yong WP, et al. Differentiation-
associated overexpression of the cyclin-dependent
kinase inhibitor p21waf-1 in human cutaneous
squamous cell carcinoma. Am J Pathol 1996;149:
1139–1146.
44 Nevins JR. The Rb/E2F pathway and cancer. Hum Mol
Genet 2001;10:699–703.
45 Serrano M. The tumor suppressor protein p16INK4a.
Exp Cell Res 1997;237:7–13.
46 Sano T, Oyama T, Kashiwabara K, et al. Expression
status of p16 protein is associated with human
papillomavirus oncogenic potential in cervical and
genital lesions. Am J Pathol 1998;153:1741–1748.
47 Ferreux E, Lont AP, Horenblas S, et al. Evidence for at
least three alternative mechanisms targeting the
p16INK4A/cyclin D/Rb pathway in penile carcinoma,
one of which is mediated by high-risk human
papillomavirus. J Pathol 2003;201:109–118.
npg_Mpath_modpathol200977
Penile verrucous carcinoma
E Stankiewicz et al
9
Modern Pathology (2009), 1–9
